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Abstract
Titanium (Ti) is a widely used material for surgical implants; total joint replacements (TJRs),
screws and plates for fixing bones and dental implants are forged from Ti. Whilst Ti inte-
grates well into host tissue approximately 10% of TJRs will fail in the lifetime of the patient
through a process known as aseptic loosening. These failures necessitate revision arthro-
plasties which are more complicated and costly than the initial procedure. Finding ways of
enhancing early (osseo)integration of TJRs is therefore highly desirable and continues to
represent a research priority in current biomaterial design. One way of realising improve-
ments in implant quality is to coat the Ti surface with small biological agents known to sup-
port human osteoblast formation and maturation at Ti surfaces. Lysophosphatidic acid
(LPA) and certain LPA analogues offer potential solutions as Ti coatings in reducing aseptic
loosening. Herein we present evidence for the successful bio-functionalisation of Ti using
LPA. This modified Ti surface heightened the maturation of human osteoblasts, as sup-
ported by increased expression of alkaline phosphatase. These functionalised surfaces
also deterred the attachment and growth of Staphylococcus aureus, a bacterium often
associated with implant failures through sepsis. Collectively we provide evidence for the
fabrication of a dual-action Ti surface finish, a highly desirable feature towards the develop-
ment of next-generation implantable devices.
Introduction
Developing surface finishes to encourage osteoblastogenesis is a continuing theme of contem-
porary bone biomaterials research. Enhancing human osteoblast (hOB) formation and
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maturation at prosthetic surfaces is predicted to secure superior implant integration and lon-
gevity. Novel ways of fabricating unique substrates includes coating bone biomaterials with
small biological agents. Importantly the selected molecules should target hOBs and their bone
marrow-derived stromal cell (BMSC) precursors. Particularly attractive are agents that partici-
pate in signalling co-operation of “cross-coupling” with key molecules central to bone forma-
tion, health and homeostasis. Candidate factors fulfilling these criteria are the simple bioactive
lysophosphatidic acids (LPAs) and/or their more stable, phosphatase-resistant analogues. The
term LPA (1-acyl-2-hydroxy-sn-glycero-3-phosphate) actually refers to a group of lysopho-
spholipids that are characterized as having a fatty acyl chain, glycerol backbone and a phos-
phate head group, different LPAs vary according to chain length and degree of saturation. The
different LPAs interact with a wide range of G protein-coupled receptors (GCPR), and mem-
bers of the LPA family are involved in diverse physiological activities such as wound healing,
cell survival, apoptosis, motility and differentiation (reviewed in [1]). Skeletal cells, including
hOBs and BMSCs, are also targets for LPAs [2]. Of particular relevance to bone formation is
the discovery that LPA co-operates with the active metabolite of vitamin D3, 1,25-dihydroxy
vitamin D3 (1,25D), to secure hOB maturation [3–5]. It is the mature osteoblast phenotype
that is responsible for the provision of a mechanically robust, mineralised matrix. The signal-
ling cross-coupling that occurs between LPA and active vitamin D3 metabolites culminates in
synergistic increases in alkaline phosphatase (ALP), an enzyme absolutely essential for bone
matrix calcification [6]. These features of LPA, its small size and ability to co-operate with
1,25D make it an especially desirable molecule for the functionalisation of titanium and
hydroxyapatite, two widely used bone biomaterials. The only other molecules reported to co-
operate with 1,25D in stimulating hOB maturation are TGF-β [7] and epidermal growth factor
[8]. Their larger size and greater cost make them less desirable contenders for biomaterial con-
jugation and they are less likely to withstand conventional sterilisation protocols.
In addition to its reported effects on hOBs, 16:0 MPPA, an LPA with an unsaturated C16
chain, has been reported to inhibit virulence factor production and biofilm formation of the
human opportunistic pathogen Pseudomonas aeruginosa [9]. 16:0 MPPA has together with
several other phospholipids such as dipalmitoyl phosphatidyl serine, dipalmitoyl phosphatidic
acid and monomyristoyl phosphatidic acid been shown to sensitize otherwise resistant P. aeru-
ginosa isolates to the actions of betalactams [10]. We have also shown that 16:0 MPPA and
monopalmitoyl phosphatidyl choline are antimicrobial against a range of gram positive bacte-
ria such as Staphylococcus aureus and Enterococcus spp [11]. Collectively LPA-functionalised
devices could be beneficial in two important ways; the enhancement of early osseointegration
by promoting hOB maturation at the surface and secondly, a substrate that is less appealing to
bacteria at the time of implantation.
Biological coating of contemporary bone biomaterials can be particularly challenging, often
requiring time consuming, complex and costly procedures. However there is an attractive, fac-
ile method for functionalising titanium devices; the use of alkane phosphonic acids (APAs)
which have a natural, high affinity for metal oxides [12] including titania (TiO2), the natural
coating of titanium. The bonds formed between TiO2 and APAs are robust, iono-covalent in
nature and are superior to those formed using silanes as no further cross-linking is required.
The nature of the APA-TiO2 bond has been reported to be mono and/or bidentate and can also
include electrostatic interactions [13,14].
Herein we report the facile functionalisation of Ti using octadecylphosphonic acid (ODPA)
for the subsequent attachment of 16:0 MPPA and a palmitoyl, phosphatase-resistant LPA ana-
logue, O-2-(hexadecyloxy)-3-methoxypropyl O-hydrogenphosphorothioate (16:0 OMPT)
[15]. The rationale for using a phosphatase-resistant LPA species over 16:0 MPPA is to pro-
duce a Ti surface finish with increased “residence time” of the tethered bioactive as native
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LPAs are susceptible to rapid hydrolysis by lipid phosphate phosphatases [16]. These modified
surfaces were evaluated for their ability to support 1,25D-induced hOB maturation. In parallel
the same surfaces were exposed to S. aureus to investigate the effect of these functionalised
materials on bacterial attachment and growth.
Materials and Methods
General
Unless stated otherwise, all reagents were of analytical grade from Sigma-Aldrich (Poole, UK).
Stocks of 16:0 MPPA (Cambridge Bioscience, Cambridge, UK) were prepared in 1:1 ethanol:
tissue culture grade water to a final concentration of 10 mM and stored at -20°C. Likewise,
1,25D (100 micromolar) was prepared in ethanol and stored at -20°C. Stable, phosphatase-
resistant 16:0 OMPT (Fig 1) was synthesized at The University of Utah as detailed below. The
compound was reconstituted in 1:1 ethanol:tissue culture grade water to a final concentration
of 10 mM and stored at -20°C. Octadecylphosphonic acid (ODPA) was dissolved in anhydrous
tetrahydrofuran to a final concentration of 1 mM in glass and stored at ambient temperature.
Synthesis of O-2-(hexadecyloxy)-3-methoxypropyl O-
hydrogenphosphorothioate (16:0 OMPT)
2-(hexadecyloxy)-3-methoxypropan-1-ol. A solution of 1-trityl-3-methyl-glycerol (2.537
g, 7.29 mmole) in 40 ml of dimethylformamide (DMF) was added sodium hydride (60% in
mineral oil, 335 mg, and 1.15 eq. 8.39 mmole). Then the reaction mixture was stirred at room
temperature for 1 hour before 1-bromohexadecane (2.67 g, 8.75 mmole, 1.2 eq.) in 10 mL
Fig 1. Structures of 16:0 MPPA, 16:0 OMPT and octadecylphosphonic acid (ODPA). The alkane phosphonic acid, ODPA, was used as a tether for the
subsequent functionalisation of titanium with 16:0 OMPT, a phosphatase-resistant LPA receptor agonist.
doi:10.1371/journal.pone.0143509.g001
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DMF and tributylammonia iodide (0.1 eq, 0.73 mmole, 269 mg) were added. The mixture was
stirred overnight at room temperature. Then 1N HCl (60 mL) was added to quench the reac-
tion, and the mixture was extracted with 100 mL EtOAc twice. The organic extract was washed
with saturated NaHCO3 solution, followed by a saturated NaCl solution. Solvent was removed
at reduced pressure and the crude mixture was purified on silica column (EtOAc:hexane 5/95)
to give crude hexadecyl ether (1.537 g, 2.67 mmole, 37%), which was directly dissolved into 30
mL dichloromethane and then 3 mL trifluoroacetic acid was added. The reaction mixture was
stirred for 1 hour at room temperature. Then solid sodium bicarbonate was added slowly to
neutralize the reaction mixture, followed by 100 mL of water. The organic layer was separated
and the water layer was extracted by dichloromethane (100 mL) twice. All organic layers were
combined and dried over sodium sulphate. The organic solvent was concentrated and the resi-
due was purified on silica column (EtOAc:hexane 5/95, 15/85) to give 2-(hexadecyloxy)-
3-methoxypropan-1-ol (722 mg, 2.19 mmole, 82%) as a waxy solid.
1HNMR (CDCl3) 3.70–3.75 (m, 1H), 3.55–3.65 (m, 2H), 3.42–3.52 (m, 4H), 3.34 (s, 3H),
1.51–1.58 (m, 2H), 1.20–1.38 (m, 26H).
O,O-Bis(2-cyanoethyl) O-2-(hexadecyloxy)-3-methoxypropylphosphorothioate. Di
(2-cyanoethyl) diisopropylphosphorodiamidite (271 mg, 1 mmole) in 2 mL dichloromethane
was added under an argon atmosphere to a solution of the above hexadecyl ether (330 mg 1
mmole) and 1H-tetrazole (70 mg 1 mmole) in 10 mL dry dichloromethane. After stirring for 1
hour, sulfur (32 mg, 1 mmole) and CS2/pyridine (0.2 mL, 1:1 v/v) were added. After stirring at
room temperature for another 2 hours, the reaction mixture was filtered and filtrate was
washed with brine, dried over sodium sulphate, and concentrated. The residue was purified on
silica column (EtOAc:hexane 1:1, 1:2) to give O,O-Bis(2-cyanoethyl) O-2-(hexadecyloxy)-
3-methoxypropylphosphorothioate (280 mg, 0.53 mmole, 53%) as a waxy solid.
1HNMR (CDCl3) 4.21–4.35 (m, 5H), 4.08–4.12 (m, 1H), 3.51–3.62 (m, 3H), 3.46–3.48 (m,
2H), 3.37 (s, 3H), 2.78 (t, J = 6.0 Hz, 4H), 1.51–1.71 (m, 2H), 1.20–1.38 (m, 26H), 0.88 (t,
J = 6.8 Hz, 3H); 31P NMR (CDCl3) 68.8.
Sodium O-2-(hexadecyloxy)-3-methoxypropyl O-hydrogenphosphorothioate (“16:0
OMPT”). Tert-butylamine (0.2 mL) was added to a solution of the above O,O-bis(2-cya-
noethyl) O-2-(hexadecyloxy)-3-methoxypropylphosphorothioate (150 mg, 0.27 mmole) in
CH3CN (1 mL) under N2 followed by the addition of bistrimethylsilylacetamide (0.2 mL).
After 48 hours, the reaction mixture was concentrated and the residue was purified on silica
column (EtOAc:CH3OH, 9:1) to afford 91 mg of the ammonium salt of the 16:0 analogue of
OMPT as a light yellow oil (0.21 mmole, 78%). The monosodium salt was obtained via ion
exchange resin (Dowex 200 Na+ form).
1HNMR (CDCl3) 4.05–4.22 m, 2H), 3.41–3.75 (m, 5H), 3.37 (s, 3H), 1.51–1.71 (m, 2H),
1.20–1.38 (m, 26H), 0.88 (t, J = 7.2 Hz, 3H); 31P NMR (CDCl3) 52.7. HRMS (MALDI) for
C20H42NaO5PS [M
+ +1]: found 448.9057, calculated 448.2388.
Lysophosphatidate-functionalisation of Ti specimens
Titanium (Ti) discs (12.7 mm diameter and 2.5 mm thickness) of orthopaedic grade titanium
were a generous gift from Corin (Cirencester, UK). To encourage oxide formation Ti discs
were either oven baked at 160°C overnight (~18 hours) or treated with Piranha solution as
described by us previously [17]. Briefly, Piranha solution was prepared by combining equal vol-
umes (20 mL) of ice-cold concentrated sulphuric acid and 30% (w/v) hydrogen peroxide.
[Please note that Piranha solution is highly corrosive and oxidative and should be handled with
care]. Once mixed the resultant solution was allowed to reach room temperature before use. Ti
discs were steeped in Piranha solution for 2 hours under gentle stirring at ambient temperature.
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Discs were subsequently washed and patted dry. Oven-baked Ti, Piranha-treated Ti and un-
pre-treated Ti discs were then immersed in 1 mMODPA in tetrahydrofuran (THF) for 1 hour
at ambient temperature. The Ti specimens were allowed to dry in a fume cupboard at ambient
temperature, and then given two 5-minute rinses in THF, allowed to dry followed by baking
overnight at 160°C. Each Ti disc was then placed into a well of a 24-well tissue culture plate
and bathed in 1 ml of 100 micromolar 16:0 OMPT in 50% aqueous (tissue culture grade water)
ethanol, and samples left overnight at ambient temperature. Then the discs were rinsed in tis-
sue culture-grade water and allowed to dry, at ambient temperature in a tissue-culture cabinet.
Human MG63 osteoblasts
Human osteoblast-like cells (MG63, ECACC, item code: 86051601) were cultured in conven-
tional tissue culture flasks (250 mL, Greiner, Frickenhausen, Germany) in a humidified atmo-
sphere at 37°C and 5% CO2. Although osteosarcoma derived, MG63 cells exhibit features in
common with human osteoblast precursors or poorly differentiated osteoblasts. Specifically,
these cells produce type I collagen with no or low basal osteocalcin (OC) and ALP [18]. How-
ever, when MG63 cells are treated with 1,25D, cell proliferation is inhibited and there is an
accompanying, enhanced expression of OC. When MG63 cells are co-stimulated with 1,25D
and selected growth factors, e.g., LPAs, then there is a marked, synergistic increase in ALP
reflecting transition to the mature phenotype. Thus, the application of these cells to assess the
compatibility of LPA-functionalised biomaterials for orthopaedic applications is entirely
appropriate.
MG63 cells were grown to confluence in Dulbecco’s modified Eagle medium (DMEM)/F12
nutrient mix (Gibco, Paisley, Scotland) supplemented with sodium pyruvate (1 mM final con-
centration), L-glutamine (4 mM), streptomycin (100 ng/mL), penicillin (0.1 units/mL) and
10% v/v foetal calf serum (Gibco, Paisley, Scotland). The growth media was also supplemented
with 1% of a 100x stock of non-essential amino acids. Once confluent, MG63 cells were subse-
quently dispensed into 24-well plates (Greiner, Frickenhausen, Germany) containing control
and 16:0 OMPT functionalised Ti surfaces. In each case, wells were seeded with 1 mL of a
4x104 cells/mL suspension (as assessed by haemocytometry) in serum free medium supple-
mented with 100 nM 1,25D. Cells were then cultured for 3 days, the Ti specimens removed and
transferred to clean plates to ascertain cell number and total ALP activity for cells associated
with the metal samples.
Enumeration of MG63 cells
An assessment of cell number was performed using a combination of the tetrazolium com-
pound 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxy-phenyl)-2-(4-sulfophenyl)-2H-tet-
razolium, innersalt (MTS, Promega, UK) and the electron-coupling reagent phenazine
methosulphate (PMS). Each compound was prepared separately in pre-warmed (37°C) phenol
red-free DMEM/F12, allowed to dissolve, and then combined so that 1 mL of a 1 mg/mL solu-
tion of PMS was combined to 19 mL of a 2 mg/mL solution of MTS. A stock suspension of
MG63 cells (1x106 cells/mL) was serially diluted in growth medium to give a series of known
cell concentrations down to 2.5x104 cells/mL. Each sample (0.5 mL in a microcentrifuge tube)
was spiked with 0.1 mL of the MTS/PMS reagent mixture and left for 45 minutes within a tis-
sue culture incubator. Once incubated, the samples were centrifuged at 900 rpm to pellet the
cells and 0.1 mL of the supernatants dispensed onto a 96-well microtitre plate and the absor-
bance read at 492 nm using a multiplate reader. Plotting the absorbances against known cell
number, as assessed initially using haemocytometry, enabled extrapolation of cell numbers for
the experiments described herein.
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Total alkaline phosphatase activity
An assessment of ALP activity is reliably measured by the generation of p-nitrophenol (p-NP)
from p-nitrophenylphosphate (p-NPP) under alkaline conditions. The treatment of cells to
quantify ALP activity was similar to that described by us recently [19]. Briefly, the MTS/PMS
reagent was removed and the monolayers incubated for a further 15 minutes in fresh phenol
red-free DMEM/F12 to remove the residual formazan. Following this incubation period, the
medium was removed and the monolayers lysed with 0.1 mL of 25 mM sodium carbonate (pH
10.3), 0.1% (v/v) Triton X-100. After 2 minutes, each well was treated with 0.2 mL of 15 mM p-
NPP (di-Tris salt, Sigma, UK) in 250 mM sodium carbonate (pH 10.3), 1 mMMgCl2. Lysates
were then left under conventional cell culturing conditions for 1 h. After the incubation period,
0.1 mL aliquots were transferred to 96-well microtitre plates and the absorbance read at 405
nm. An ascending series of p-NP (25–500 micromolar) prepared in the incubation buffer
enabled quantification of product formation. Unless stated otherwise, total ALP activity is
expressed as the mean micromolar concentration of p-NP per 100,000 cells, as extrapolated
from the MTS/PMS assay described above.
Growth kinetics of S. aureus
Unless stated otherwise all media components used for growth of bacteria were from Sigma.
Bacterial growth of the Methicillin Resistant strain S. aureus 43484 [20] was investigated in a
96 well microtiter plate. A single colony of strain MRSA 43484 from an overnight LB plate was
inoculated into Luria Broth (LB) media and grown until exponential phase (around 4 hours) at
37°C and shaking of 200 rpm. Bacteria were then diluted 100 times in LB or minimal media as
outlined and added calcium chloride when described. Minimal media consisted of M9 minimal
media containing 2% glycerol, 0.5% cas-amino acids, 0.2 microgram/mL niacin, and 0.2 micro-
gram/mL thiamine, and 2 mMmagnesium chloride. EDTA, 16:0 OMPT and 16:0 MPPA were
dissolved and diluted in PBS in two times the final concentration in a 96 well plate. Then the
diluted compounds were mixed with equal amounts of the bacterial culture in the relevant
media (LB or minimal media). Absorbance at OD 450 nm of the 96 well microtiter plate was
read every 20 minutes the following 15 hours using a BMG Labtech FLUOstar OPTIMA
Microplate Reader running at 37°C.
Flow cytometry
A single colony of MRSA 43484 was inoculated into LB. After 4 hours incubation, this culture
was used to inoculate LB media containing either 16:0 OMPT, 16:0 MPPA or EDTA at the con-
centrations specified or control, and incubated over night at 37°C, shaking at 200 rpm. Bacte-
rial cultures were then washed in PBS (GIBCO, Grand Island, NY) and adjusted to
approximately OD 600 nm 0,002. The bacterial suspension were then stained with 500nM pro-
pidium iodide for five minutes at 30°C before analysis on an Accuri C6 standard set-up flow
cytometer (Accuri, Ann Arbor, MI). Initial gating of bacteria was performed using forward
scatter (FSC-H) and side scatter (SSC-H). The gated population was further analysed using
excitation of PI at 488 nm and emission at 670/LP nm (FL-3). The flow cytometer was operated
at the Slow Flow Rate setting (14 microliter sample/minute).
Bacterial adhesion to functionalised Ti
A single colony of MRSA 43484 was inoculated into LB media and grown overnight to station-
ary phase at 37°C and shaking (200 rpm). The culture was then washed once in LB and diluted
to OD 600 nm 0,010 (corresponding to approximately 3x107 CFU pr. mL) with fresh LB. 1 mL
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pr. well of the bacterial suspension was added to the wells of a 24 well plate (Nunc, Roskilde,
Denmark) and Ti discs were added to the wells. The 24 well plate with Ti discs and bacteria
was incubated for 8 h at 37°C. The Ti discs were then washed briefly in PBS and transferred to
new wells with sterile PBS to loosen adhering bacteria. The plate was then stored at 4°C for 24–
72 hours. The Ti discs were removed and CFU pr. mL of the detached bacteria (in PBS) was
determined by spot plating (in duplicate). Four discs per group (control, OMPT or MPPA)
were used and the experiment performed four times. To determine whether the coating on the
Ti discs remained their activity after one time use, in one experiment the discs were reused:
after the experiment the slides rinsed with soap and distilled water, padded dry and finally
autoclaved and used as described above. During the rinsing procedure, mixing of the Ti discs
was avoided by using separate glass vials for the different types of surface modification.
Scanning electron microscopy
Bacterial adhesion was performed as described above, but instead of detaching bacteria by
incubation in PBS, the briefly rinsed Ti discs with adhering bacteria were fixed in 2% glutaral-
dehyde in PBS, and postfixed in 1% OsO4. Samples were then dehydrated in ethanol, critical
point-dried using CO2, and sputter-coated with gold. Samples were investigated using a Philips
XL Feg30 scanning electron microscope operated at 2 kV. The number of adherent bacteria pr.
micrometer2 was determined by manual counting of resulting images. Three images captured
from different, random locations at the Ti disc were counted for each condition. For each sam-
ple the number of bacteria adhering to at least 10000 micrometer2 was determined. The SEM
experiment was performed once.
Statistical analyses
Unless stated otherwise, all the cell culture experiments described above were performed three
times and all data were subject to a one-way analysis of variance (ANOVA) to test for statistical
significance as we have reported previously [5]. When a p value of< 0.05 was found, a Tukey
multiple comparisons post-test was performed between all groups. All data are expressed as the
mean together with the standard deviation. Investigations of adhesion of MRSA to Ti discs
were also performed at least three times unless otherwise stated and data were analysed with a
one-way ANOVA using Dunnett’s multiple comparison post-test between control and treat-
ment groups (functionalised Ti discs) for p values< 0.05.
Results
3.1 16:0 OMPT and 1,25D co-operate to promote human osteoblast
maturation
Cell number increased significantly in the presence of 16:0 OMPT (10 micromolar), while
1,25D (100 nM) caused a significant reduction in cell number. However, the combined effect
of 16:0 OMPT and 1,25D gave cell numbers similar to untreated cells (Fig 2A). After three days
of culture, the extent of maturation of the osteoblasts in response to the active vitamin D3
metabolite; 1,25D and 16:0 OMPT was determined by measurement of alkaline phosphatase
activity via quantification of p-NP from p-NPP. Co-stimulation of MG63 osteoblasts with
1,25D and 16:0 OMPT led to clear, synergistic, increases in ALP activity, as supported by ele-
vated p-NP production (Fig 2B).
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Fig 2. Growth andmaturation of human (MG63) osteoblasts in response to 16:0 OMPT and 1,25D. A.MG63 osteoblasts were treated with 1,25D
(100nM), 16:0 OMPT (micromolarμM) or a combination of these agents and left for three days under conventional cell culturing conditions prior to an
assessment of cell growth. As anticipated for the pro-differentiating effects of 1,25D, there were fewer cells (*p<0.01 1,25D versus control) at the end of the
culture period. In contrast the application of 16:0 OMPT led to a significant increase in cell numbers (**p<0.01 16:0 OMPT versus control). B. Alkaline
phosphatase (ALP) is expressed in greater abundance as osteoblasts progress from an immature to a more differentiated phenotype. Enzyme activity is
reliably monitored via the hydrolysis of p-nitrophenyl phosphate to p-nitrophenol (p-NP). The co-stimulation of MG63 cells with 100nM 1,25D and 16:0 OMPT
yielded significant increases in total ALP activity by 72 h (*p < 0.001 versus agents in isolation). In each case the data shown are the mean + SD of 4 replicate
samples and are a representative from three independent experiments.
doi:10.1371/journal.pone.0143509.g002
Bio-Functionalised Titanium for Bone Regenerative Applications
PLOS ONE | DOI:10.1371/journal.pone.0143509 November 25, 2015 8 / 17
16:0 OMPT-functionalised Ti enhances 1,25D-induced MG63
maturation
Human MG63 osteoblasts were seeded onto ODPA or ODPA-16:0 OMPT modified Ti speci-
mens. Ti specimens subjected to ODPA-16:0 OMPT functionalisation caused a significantly
higher degree of 1,25D-induced osteoblast maturation than ODPA alone (Fig 3). Moreover,
pretreatment of the Ti specimens before surface modification either by baking or Piranha treat-
ment gave even higher levels of p-NP (p<0.001 versus ODPA control Ti) and thus MG63
osteoblast maturation than direct surface modification (16:0 OMPT ambient, p<0.01 versus
ODPA control Ti). No difference was found between baking and Piranha pretreatment with
regard to MG63 maturation. Baking as pre-treatment option was used in all subsequent modi-
fications for the microbiological studies described in the following.
Antibacterial effects of 16:0 MPPA, 16:0 OMPT and EDTA
We have previously shown that 16:0 MPPA is antibacterial against a range of bacteria [11]. In
order to investigate whether the artificial LPA analogue 16:0 OMPT had similar properties we
Fig 3. 16:0 OMPT-functionalised Ti enhances 1,25D-induced MG63 cell maturation. Solid Ti discs (48 in
total) were equally divided as follows: some were subjected to either Piranha solution (OMPT Piranha) or
baked at 160°C overnight (OMPT baked) prior to steeping in ODPA for an hour under ambient conditions.
Recovered samples were then exposed to 16:0 OMPT (0.1mM in 50% aqueous ethanol) overnight. Some
discs were treated with ODPA alone (control) and others ODPA followed by 16:0 OMPT with no prior baking
or Piranha treatment (OMPT ambient). Each group of discs were transferred to multiwell tissue culture plates
and seeded with MG63 osteoblasts in a serum-free culture medium supplemented with 100nM 1,25D. After
three days of culture an assessment of total ALP activity was performed using p-nitrophenylphosphate as
substrate and quantification of p-nitrophenol (p-NP). The concentration of p-NP for cells upon ODPA/16:0
OMPT-functionalised Ti is greater than for cells on control Ti (*p<0.01 compared to control Ti). The extent of
maturation, as supported by raised p-NP, is significantly greater still (**p<0.001 compared to control Ti) by
prior baking/Piranha treatment of the Ti samples. The data presented are a representative of three
independent experiments. In each case the data shown are the mean micromolar concentration of p-NP
normalised to 105 cells + SD of 4 replicate samples.
doi:10.1371/journal.pone.0143509.g003
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exposed the MRSA clinical strain 43484 to serial dilutions of 16:0 OMPT and 16:0 MPPA and
observed growth. We also included the chelator EDTA. Fig 4 shows that 200 μg/mL of 16:0
MPPA, 16:0 OMPT or EDTA (corresponding to 0.4 mMMPPA or OMPT or 0.5 mM EDTA)
completely abolished growth of the MRSA strain. We found that the MRSA strain was much
more sensitive to 16:0 MPPA and 16:0 OMPT in minimal media (Fig 5), where 25 microgram/
mL of either 16:0 MPPA or 16:0 OMPT was enough to inhibit growth. We further investigated
the effect of media composition. Fig 6 shows that addition of 2 mM Ca2+ abolished the growth
inhibitory effect of 16:0 MPPA and EDTA while 16:0 OMPT still inhibited growth in the pres-
ence of extra calcium.
Flow cytometry
To investigate whether 16:0 OMPT and 16:0 MPPA were bactericidal or bacteriostatic we
investigated the uptake of the nonviable dye propidium iodide (PI) by MRSA grown in the
Fig 4. Lysophosphatidic acid species inhibit the growth of MRSA in Luria broth. The effect of different concentrations of 16:0 MPPA, 16:0 OMPT and
EDTA on growth of MRSA 43484 in Luria broth. Legend: 16:0 MPPA; black (control), red (1,56 microgram/mL), green (6,3 microgram/mL), blue (25
microgram/mL). 16:0 OMPT; black (control), red (1,56 microgram/mL), green (6,3 microgram/mL), blue (25 microgram/mL). EDTA; black (control), green (6,3
microgram/mL), blue (25 microgram/mL), grey (0.1mg/mL).
doi:10.1371/journal.pone.0143509.g004
Fig 5. Lysophosphatidic acid species inhibit the growth of MRSA in minimal media. The effect of different concentrations of 16:0 MPPA, 16:0 OMPT
and EDTA on growth of MRSA 43484 in minimal media. Legend: 16:0 MPPA; black (control), red (1,56 microgram/mL), green (6,3 microgram/mL), blue (25
microgram/mL). 16:0 OMPT; black (control), red (1,56 microgram/mL), green (6,3 microgram/mL), blue (25 microgram/mL). Notice that the symbols of the
control almost hides the symbols of 6,3 microgram/mL EDTA.
doi:10.1371/journal.pone.0143509.g005
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presence of these compounds. The concentration of MPPA, OMPT and EDTA were adjusted
to achieve limited growth; that is OD600 1.5 compared to untreated bacteria that achieved an
OD600 of 3.0. Fig 7 shows that the three compounds in the concentrations tested caused an
increased uptake of PI, suggesting all three compounds to be bactericidal.
Adhesion of MRSA to 16:0 OMPT and 16:0 MPPA functionalised Ti
discs
Aiming to apply the 16:0 OMPT and 16:0 MPPA to functionalise Ti for implant use we investi-
gated the adhesion of MRSA strain 43484 to 16:0 MPPA or 16:0 OMPT functionalised Ti discs.
Fig 8A shows that both 16:0 MPPA and 16:0 OMPT reduced adhesion of MRSA to Ti discs.
Functionalisation using a linker such as ODPA should make the binding of compounds to the
surface very durable through interaction of the hydrophobic alkyl chains of both the ODPA
and the LPA/LPA analogue. To test this, we reused the Ti discs in a new experiment after care-
ful rinsing and autoclaving of the Ti discs. Fig 8B shows that in the reuse experiment the anti-
adhesive effect reached the same level as the first round of the experiment. As mentioned above
we found that adding Ca2+ abolished the growth inhibitory effect of 16:0 MPPA, and we
wanted to investigate whether extra Ca2+ would also affect the anti-adhesive effect of 16:0
Fig 6. Growth of MRSA in response to lysophosphatidic acids and the influence of calcium.Growth curves of MRSA 43484 in minimal media showing
the effect of Ca2+. Black (control), red (control + 2 mM Ca2+), green (100 μg/mL 16:0 MPPA/16:0 OMPT/EDTA), Blue 0.1mg/mL 16:0 MPPA/16:0 OMPT/
EDTA + 2 mMCa2+).
doi:10.1371/journal.pone.0143509.g006
Fig 7. Flow cytometry of MRSA stained with PI: effect of lysophosphatidic acid species and EDTA on viability.Histograms of MRSA 43484 stained
with propidium iodide (PI), gated on forward and side scatter. Bacteria were grown in the presence of 0.1mg/mL 16:0 MPPA, 50 microgram/mL 16:0 OMPT,
0.1mg/mL EDTA or in the absence of compounds (control). Markers show the percentage of PI stained, and hence nonviable, population.
doi:10.1371/journal.pone.0143509.g007
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MPPA and/or 16:0 OMPT. Fig 8C shows that adding 2 mM Ca2+ did not affect the anti-adhe-
sive properties of 16:0 MPPA or 16:0 OMPT functionalisation. Fig 8D–8G shows that growth
in the media above the functionalised Ti discs (Fig 8A–8C) were not affected, suggesting that
low/no 16:0 MPPA or 16:0 OMPT was released from the Ti discs into the media.
Scanning Electron Microscopy
Scanning Electron Microscopy (SEM) was performed on functionalised Ti discs with adherent
MRSA bacteria. Examples of resulting images are shown in Fig 9. Manual counting of adherent
bacteria/micrometerm2 showed that significantly fewer bacteria adhered to the 16:0 OMPT
and 16:0 MPPA functionalised Ti compared to the control. Interestingly, the images showed
that while the bacteria adhering to the control Ti discs had a very rough appearance, bacteria
adhering the 16:0 OMPT and especially the 16:0 MPPA functionalised Ti discs appeared
smooth and with less extracellular matrix material.
Discussion
Developing novel biomaterial coatings that enhance early osseointegration yet deter the attach-
ment of bacteria are especially desirable properties for future orthopaedic and dental implant
devices. The simple pleiotropic lipid, LPA and/or selected LPA analogues, could represent can-
didate molecules for coating Ti. Over a decade ago Laux and colleagues [9] described how 16:0
MPPA (palmitoyl LPA) inhibited the growth and virulence of P. aeruginosa. 16:0 MPPA is a
Fig 8. Lysophosphatidiate-functionalised titanium inhibits MRSA adhesion. Effect of functionalised Ti on bacterial adhesion. A-C) CFU of adherent
MRSA pr. Ti disc after detachment. A) CFU pr. Ti disc; control or functionalised with either 16:0 OMPT or 16:0 MPPA. B) *Reuse of the same discs as in A)
after washing and autoclaving. C) Effect of addition of 2 mM Ca2+ on MRSA adhesion to Ti discs. In each instance four discs were used for each of the
different Ti surface treatments. D-F) End point OD450 of planktonic bacteria in the wells containing the Ti discs in A-C. (*p<0.05, **p<0.005 and ***p<0.0005
compared to control). Each of the figures is a representative of four independent experiments.
doi:10.1371/journal.pone.0143509.g008
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naturally occurring LPA found in biological fluids including bronchoalveolar lavage (BAL),
serum and plasma [21–23]. Interestingly, exposure of bacteria to this lipid made them increas-
ingly susceptible to certain antibiotics. This particular lipid species sits amongst several struc-
turally similar lysophospholipids that serve as signalling molecules to most mammalian cell
types [24] In the context of human osteoblast biology LPAs co-operate with 1,25D to enhance
their maturation [3,4] an event synonymous with bone tissue formation. Given the reported
Fig 9. Lysophosphatidate-functionalisation of titanium deters bacterial attachment and alters bacterial surface morphology. A. Scanning Electron
Microscopy images of MRSA 43484 on control and functionalised Ti surfaces. The left column shows unmodified Ti, in the centre, Ti functionalised with 16:0
OMPT, and in the right column images of bacteria upon 16:0 MPPA functionalised Ti. B.Graph depicting the data obtained for the number of bacteria
associated for each of the different Ti surfaces.
doi:10.1371/journal.pone.0143509.g009
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effects of 16:0 MPPA on bacteria suggest LPA/LPA analogues as potential adjuncts in a bone
regenerative setting and one way in which this could be realised is by coating biomaterials with
LPA/LPA analogues. Such a “dual-action” coating would be particularly appealing to reduce
potential infection risk of implantable devices whilst encouraging superior early
osseointegration.
Human osteoblasts and bone marrow stromal cells express at least three different LPA
receptor types. When stimulated with LPA/LPA analogues effects ranging from proliferation,
fibronectin binding, cytoskeletal reorganization and differentiation have been reported [2]. In
this particular investigation we found that 16:0 OMPT stimulated MG63 cell growth. When
the same cells were co-stimulated with 1,25D and 16:0 OMPT cell growth was modestly attenu-
ated and there was a synergistic increase in total ALP activity indicating a change towards a
more mature or differentiated phenotype. All of these changes essentially mirror the effects we
have seen for other LPA species on this cell type. In this study we also show that the functiona-
lisation of Ti with 16:0 OMPT, enhances 1,25D-induced MG63 maturation, as supported by
the greater total ALP activity. The effect of 16:0 OMPT functionalisation on maturation of
MG63 is particularly encouraging; mature osteoblasts are responsible for bone matrix synthesis
and mineralisation and if these events can be enhanced at the Ti surface then this could facili-
tate the process of early osseointegration.
We have previously shown that 16:0 MPPA sensitises otherwise betalactam resistant P. aer-
uginosa to the actions of ampicillin [9,10]. We have also shown that this LPA is antibacterial
against a number of Gram positive bacteria including S. aureus [11]. Here we further show that
the phosphatase resistant LPA analogue, 16:0 OMPT, is antibacterial against MRSA strain
43484. The mechanism by which the two compounds exert their effects is unclear. We have
previously reported that 16:0 MPPA precipitates in the presence of the divalent cations calcium
and magnesium and that precipitation is most noticeable with the former ion. These observa-
tions imply that 16:0 MPPA can function as a chelator [10]. Due to the clear structural similari-
ties between 16:0 MPPA and 16:0 OMPT, it is likely that 16:0 OMPT is also capable of forming
chelating micelles in the presence of divalent cations. In 1968 it was reported that EDTA
reversed ampicillin resistance in P. aeruginosa; the minimum inhibitory concentrations (MIC)
of ampicillin was reduced from 0.5mg/mL to less than 2 microgram/mL in the presence of 3.4
mM EDTA [25]. The lipopolysaccharide (LPS) layer in Gram negative bacteria such as P. aeru-
ginosa are stabilised by divalent cations (mainly Ca2+). If calcium ions are removed by treat-
ment with a chelator, LPS is liberated, and through this disruption the membrane becomes
more permeable to other agents, causing a potentiating action (reviewed in [26]). Instead of
LPS, Gram positive bacteria have surface sugars, phosphate groups and basic residues orga-
nised as teichoic acid. S. aureus teichoic acids are composed of alternating phosphate and ribi-
tol or glycerol groups, and modified with D-alanine and N-acetylglucosamine. Teichoic acids
are important for binding of Mg2+ to the S. aureus cell wall [27] and possibly other divalent cat-
ions such as Ca2+. The cell surface of S. aureus has a moderately negative net charge at neutral
pH, which is probably due to the fact that the teichoic acid contain less positively charged D-
alanine residues than negatively charged [28]. The charge of teichoic acid has been reported to
be important for primary adhesion of bacteria to a substrate surface [29], which is the initial
step of biofilm formation. Moreover, the negative charge have been reported to play a role for
resistance against glycopeptide antibiotics [30]. It is thus possible that the chelating ability of
16:0 OMPT and 16:0 MPPA is important for their antibacterial activity through membrane
destabilisation. On the other hand, chelators could also cause simple growth inhibition by
depriving the bacteria of essential cations. To investigate this we performed flow cytometry
analyses (Fig 7), which revealed that a high proportion of the cultures treated with 16:0 MPPA
and 16:0 OMPT stained positive with PI suggesting that the two compounds directly kill the
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bacteria, and not just reduce proliferation. Interestingly we found that the while the effect on
growth of 16:0 MPPA and EDTA was abolished by addition of 2 mM Ca2+, 16:0 OMPT still
inhibited growth in the presence of extra calcium (Fig 6).
The antibacterial and osteoblast maturation enhancing activity of the LPA (analogue) com-
pounds lead us to investigate bacterial adhesion to 16:0 MPPA and 16:0 OMPT functionalised
Ti discs. S. aureus adhesion to the functionalised Ti discs were significantly reduced, however,
growth in the media above the functionalised Ti discs were not affected (Fig 8). Moreover, the
antiadhesive effect was not reduced in experiments with reuse of functionalised Ti discs. Thus,
it seems that only very low or no 16:0 MPPA or 16:0 OMPT were released from the Ti discs
into the media. As we found that addition of extra calcium abolished the growth inhibitory
effect of 16:0 MPPA, we also investigated the effect of adding additional calcium to the media
in which the functionalised Ti discs were placed. However the extra added calcium did not
alter bacterial adhesion to neither 16:0 MPPA nor 16:0 OMPT-functionalised surfaces.
We also performed SEM on functionalised Ti discs with adherent MRSA bacteria. In accor-
dance with findings obtained using the CFU method, we found that significantly fewer bacteria
adhered to the 16:0 OMPT and 16:0 MPPA functionalised Ti compared to the control. The
SEM images revealed an interesting and clear difference in morphology between the bacteria
adhering to the control, which had a very uneven and coarse surface, and bacteria adhering the
16:0 OMPT and especially the 16:0 MPPA functionalised Ti discs, which appeared smooth and
with less extracellular matrix material. This suggests that 16:0 OMPT and 16:0 MPPA affect
the teichoic acid layer, destabilising the bacterial outer membrane and thereby affecting both
surface attachment and viability.
Whilst our findings offer a novel route to the biological modification of Ti we are cognisant
that considerably more research will be required to optimise the surface coating. In addition
steps to ascertain coating stability and robustness will be priority areas in realising the appli-
cation of this technology for bone regenerative applications. Specifically an assessment of
coating persistence to washing, sterilisation and the physical forces encountered during
implantation will need to be part of a wider research plan prior to any in vivo evaluation in
the future.
Conclusion
To summarise we present evidence for the successful bio-functionalisation of Ti with 16:0
MPPA/OMPT by adopting the facile pre-attachment of an APA via the natural oxide layer
of Ti. This surface finish exhibited two noteworthy properties that may help realise the appli-
cation of selected LPAs in future bone biomaterial design; in the first instance the surfaces
enhanced 1,25D-induced hOB maturation. In addition this same surface deterred the attach-
ment of S.aureus and there were noticeable differences in bacterial surface morphology
pointing to the possible loss of teichoic acid. Collectively our findings point towards the
development of a “dual action” Ti device of which similar technologies have yet to be
reported.
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